Literature DB >> 16805087

Role of CD4+ T cells in a protective immune response against Cryptococcus neoformans in the central nervous system.

William C Uicker1, James P McCracken, Kent L Buchanan.   

Abstract

Cryptococcosis is a life-threatening disease caused by the encapsulated yeast, Cryptococcus neoformans. Although infection with C. neoformans is initiated in the lungs, morbidity and mortality is mostly associated with infections of the central nervous system (CNS). Individuals with deficiencies in cell-mediated immunity, such as patients with AIDS, are more susceptible to disseminated cryptococcosis, highlighting the importance of cell-mediated immunity and CD4+ T cells in host resistance against C. neoformans. Using a mouse model of cryptococcal meningoencephalitis, we have shown that immunization of mice with a cryptococcal antigen induced a protective immune response that crossed the blood-brain barrier and initiated an immune response directly in the CNS if C. neoformans was present. The regional protective response was characteristic of a Type-1 (Th1) response in the types of cells present at the site of infection and in the cytokines and chemokines expressed. Here, we extend those findings and report that CD4+ T cells are required for survival of immune mice infected directly in the brain with C. neoformans and sensitized CD4 + T cells can transfer partial protection to naive mice infected intracerebrally with C. neoformans. Furthermore, CD4 + T cells were also important for optimal infiltration of inflammatory cells at the site of infection and in the expression of cytokines and chemokines associated with protection in the brain. Lastly, CD4+ T cells were required for optimal regional production and secretion of IFNgamma and in the significantly increased expression of iNOS in C. neoformans-infected brains of immune mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16805087     DOI: 10.1080/13693780500088424

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  13 in total

1.  Antifungal therapy in a murine model of disseminated infection by Cryptococcus gattii.

Authors:  Enrique Calvo; F Javier Pastor; M Mar Rodríguez; Isabel Pujol; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

2.  Fungal flora of Nigerian currency notes in circulation in Benin City, Nigeria.

Authors:  F I Okungbowa; A P O Dede
Journal:  Indian J Microbiol       Date:  2010-11-25       Impact factor: 2.461

3.  Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and cryptococcosis-associated immune reconstitution inflammatory syndrome.

Authors:  Christina C Chang; Saleha Omarjee; Andrew Lim; Tim Spelman; Bernadett I Gosnell; William H Carr; Julian H Elliott; Mohamed-Yunus S Moosa; Thumbi Ndung'u; Martyn A French; Sharon R Lewin
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

4.  Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan.

Authors:  Kausik Datta; Andrew Lees; Liise-anne Pirofski
Journal:  Clin Vaccine Immunol       Date:  2008-06-04

5.  Cytomegalovirus Viremia Associated With Increased Mortality in Cryptococcal Meningitis in Sub-Saharan Africa.

Authors:  Caleb Skipper; Mark R Schleiss; Ananta S Bangdiwala; Nelmary Hernandez-Alvarado; Kabanda Taseera; Henry W Nabeta; Abdu K Musubire; Sarah M Lofgren; Darin L Wiesner; Joshua Rhein; Radha Rajasingham; Charlotte Schutz; Graeme Meintjes; Conrad Muzoora; David B Meya; David R Boulware
Journal:  Clin Infect Dis       Date:  2020-07-27       Impact factor: 9.079

6.  Evaluation of MycAssay™ Aspergillus for diagnosis of invasive pulmonary aspergillosis in patients without hematological cancer.

Authors:  Jesús Guinea; Camilo Padilla; Pilar Escribano; Patricia Muñoz; Belén Padilla; Paloma Gijón; Emilio Bouza
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

7.  Cerebrospinal fluid cytokine profiles predict risk of early mortality and immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis.

Authors:  Joseph N Jarvis; Graeme Meintjes; Tihana Bicanic; Viviana Buffa; Louise Hogan; Stephanie Mo; Gillian Tomlinson; Pascale Kropf; Mahdad Noursadeghi; Thomas S Harrison
Journal:  PLoS Pathog       Date:  2015-04-08       Impact factor: 6.823

8.  CD4+ T Cells Orchestrate Lethal Immune Pathology despite Fungal Clearance during Cryptococcus neoformans Meningoencephalitis.

Authors:  Lori M Neal; Enze Xing; Jintao Xu; Jessica L Kolbe; John J Osterholzer; Benjamin M Segal; Peter R Williamson; Michal A Olszewski
Journal:  MBio       Date:  2017-11-21       Impact factor: 7.867

9.  Diagnostic Challenges of Cryptococcus neoformans in an Immunocompetent Individual Masquerading as Chronic Hydrocephalus.

Authors:  Kedar R Mahajan; Amity L Roberts; Mark T Curtis; Danielle Fortuna; Robin Dharia; Lori Sheehan
Journal:  Case Rep Neurol Med       Date:  2016-07-20

10.  A Retrospective Cohort Study of Lesion Distribution of HIV-1 Infection Patients With Cryptococcal Meningoencephalitis on MRI: Correlation With Immunity and Immune Reconstitution.

Authors:  Shuang Xia; Xueqin Li; Yanbin Shi; Jinxin Liu; Mengjie Zhang; Tenghui Gu; Shinong Pan; Liucun Song; Jinsheng Xu; Yan Sun; Qingxia Zhao; Zhiyan Lu; Puxuan Lu; Hongjun Li
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.